Hycons (Medicine) Overview

  • Year Founded
  • 2024

Year Founded

  • Status
  • Private

  • Employees
  • 3

Employees

  • Latest Deal Type
  • Early Stage VC
  • (In Progress)

  • Investors
  • 2

Hycons (Medicine) General Information

Description

Developer of hydrophobic tag-based protein degradation therapeutics designed to improve targeted cancer treatment. The company develops degrader-antibody conjugate (DAC) technologies and linker platforms that utilize hydrophobic tag protein degradation mechanisms and molecular modeling, enabling pharmaceutical and biotechnology companies to improve drug delivery efficiency, accelerate drug development, and expand treatment options for cancer and other complex diseases.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • Hoegi-dong
  • Dongdaemun-gu
  • Seoul
  • South Korea
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Vertical(s)
Corporate Office
  • Hoegi-dong
  • Dongdaemun-gu
  • Seoul
  • South Korea

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Hycons (Medicine) Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC 22-Sep-2025 In Progress Generating Revenue
2. Accelerator/Incubator 01-Jan-2025 Completed Generating Revenue
1. Accelerator/Incubator 01-Aug-2024 Completed Generating Revenue
To view Hycons (Medicine)’s complete valuation and funding history, request access »

Hycons (Medicine) Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Hycons (Medicine) Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Jeju National University Startup Support Accelerator/Incubator
Seoul Biohub Accelerator/Incubator
To view Hycons (Medicine)’s complete investors history, request access »

Hycons (Medicine) FAQs

  • When was Hycons (Medicine) founded?

    Hycons (Medicine) was founded in 2024.

  • Where is Hycons (Medicine) headquartered?

    Hycons (Medicine) is headquartered in Seoul, South Korea.

  • What is the size of Hycons (Medicine)?

    Hycons (Medicine) has 3 total employees.

  • What industry is Hycons (Medicine) in?

    Hycons (Medicine)’s primary industry is Drug Discovery.

  • Is Hycons (Medicine) a private or public company?

    Hycons (Medicine) is a Private company.

  • What is Hycons (Medicine)’s current revenue?

    The current revenue for Hycons (Medicine) is .

  • Who are Hycons (Medicine)’s investors?

    Jeju National University Startup Support and Seoul Biohub have invested in Hycons (Medicine).

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process